Search Results



Article Topics

Your search for Jonathan A. Ledermann, MD, and Robert L. Coleman, MD matches 1 pages

Showing 1 - 1


gynecologic cancers

ARIEL3 Investigators Clarify the Effects of Rucaparib on the Liver

PRIMARY RESULTS from the randomized, placebo-controlled, phase III study ARIEL3—presented at the European Society for Medical Oncology (ESMO) 2017 Congress and published recently in The Lancet1—demonstrated that maintenance treatment with the poly(ADP-ribose) polymerase (PARP) inhibitor rucaparib ...

Advertisement



Advertisement


Advertisement